Tylla Annamuhammedova

Ongoing Master's student in Applied Biotechnology in the "University of Rome Tor Vergata" with experience in proteomics, cytogenetics, and molecular genetics laboratories. As a team P

proposed a single-shot gene therapy for Multiple Sclerosis in Rare Disease Challenge 2022 in Istanbul, and was awarded a silver medal. Organized and dependable candidate successful at managing multiple priorities with a positive attitude. Willingness to take on added responsibilities to meet team goals. Published a review article for the press room of Jacinto Convit World Organization, "Factors that contribute to the development of breast cancer." Additionally taking the "Molecular Microbiology" course in the "Crispr Biotech Engineering" platform. Have successfully passed gene therapy training. Possess strong research, team and independent work, and communication skills with fluency in Turkmen, English, Russian, Turkish.

• Fundamentals of Immunology: Innate Immunity and B-cell Function, Coursera, 09/2020
• Molecular Dietetics: Genes, Food and Health, Coursera, 09/2020
• The Science of Gastronomy, Coursera, 08/2020
• Designing Your Personal Weight Loss Plan, Coursera, 11/2020
• BAUGEN'21 Career Conference, Bahcesehir University, 09/2021
• 3rd International Genetics and Bioengineering Student Congress, Yeditepe University, 03/2020
• BAUGEN'20 Career Conference, Bahcesehir University, 02/2020
• SB
• BAK 1. Ulusal Öğrenci Kongresi GENETİK, Sağlık Bilimler
• Niversitesi, 05/2022
• Rare Disease Challenge, RaDiChal'22, 09/2022
• BAUCRISPR'22, Bahcesehir University, 12/2022